Integrative risk model of cHL. The final Cox model integrates the MRS and clinical variable stage IV. Patients in quartiles 1, 2, and 3 have comparable FFS rates at 5 years (76.4%, 79.3%, and 69.7%, respectively) whereas patients in quartile 4 show a 5-year FFS of 24.3% (P < .001).